Catalent, Inc.
Somerset, NJ · CIK 0001596783 · Software
Contract drug development and manufacturing services (CDMO) for pharmaceutical companies
catalent.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 0
- Raised
- $650M
- 1 Form D · May 2019
- 88 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 25
- 6 granted · 19 pending
- Sector median: 0
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $650,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1630 | SmartX Technology Solutions Inc. | — | $42M |
| 1631 | Facebank Inc. | — | $4.3M |
| 1632 | System AI, Inc. | — | $152K |
| 1633 | Catalent, Inc. | — | $650M |
| 1634 | Symbolic Capital Partners, Ltd. | — | $850K |
| 1635 | Equity Risk Sciences, Inc. | — | $565K |
| 1636 | Phoenix Vision, Inc. | — | $15K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Madhavan BalachandranDirector
- J. CarrollDirector
- John ChiminskiDirector · Executive Officer
- Rolf ClassonDirector
- Rosemary CraneDirector
- Steven FasmanExecutive Officer
- John GreischDirector
- Wetteny JosephExecutive Officer
- Christa KreuzburgDirector
- Gregory LucierDirector
- Alessandro MaselliExecutive Officer
- Donald Morel Jr.Director
- Jack StahlDirector
- Peter ZippeliusDirector
Patents
- Pharmaceutical Compositions Using Non-animal Origin Matrix Formers And Methods Of Making Thereofapplication
- Pharmaceutical Formulations Of Naproxen For Soft Gel Encapsulation And Combinations Thereofgranted
- Methods Of Preparing Multiphase Statin And OMEGA-3 Fatty Acid Soft Capsule Formulationsgranted
- Minimizing Agglomeration Of Drug Particle Coating Material During Storage To Stabilize Disintegration Times Of Pharmaceutical Productsgranted
- Liquid Formulations Of Ivermectin Compositions And Use In Gelatin Dosage Formsapplication
- Vectors For Protein Manufactureapplication
- Preserving Functionally-coated Api Particles Produced By Solventless Mixing Processes In Aqueous Suspensiongranted
- Increasing Permeation For Pre-gastric Absorption Of Active Pharmaceutical Ingredientsapplication
- Eva Segmented Intravaginal Rings Containing Progesteroneapplication
- Density Flow Meter For Pharmaceutical Formulation Dosinggranted
- Multifunctional Protein Molecules Comprising Decorin And Use Thereofapplication
- Segmented Eva Intravaginal Ringsapplication